Delivery Order SPE2DB20D7061-SPE2DB24FSNC5
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,035.41 firm fixed-price delivery order is for the supply of Telmisartan 20 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of April 21, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,356.61 delivery order covers the supply of Telmisartan-HCTZ 80-12.5 mg tablets to support military healthcare programs. The contract has a period of performance through May 11, 2023 and utilizes a firm fixed price pricing structure. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,097.35 for the supply of Telmisartan 20 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and does not have a set-aside designation, indicating open competition. The contract is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (SPE2DB20D3101|SPE2DB21FK3E6) valued at $2,663.63 for the supply of Telmisartan 20 mg tablets. The award was made by the Defense Logistics Agency (DLA), a defense agency, to support military healthcare programs. The contract has a completion date of August 24, 2021 and is a Firm Fixed Price type. No set-aside designation was used, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $90,191.19 for the supply of Telmisartan-HCTZ 40-12.5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of December 1, 2023 and is a firm fixed-price type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $3,846.24, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Telmisartan 80 mg Tablets in 30-count packages. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,563,045,338 units of the pharmaceutical product Telmisartan 40 mg tablets. The $1,780.90 delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The contract has an ultimate completion date of December 11, 2023 and utilizes a firm fixed price pricing type. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,012.18 firm fixed-price delivery order is for the supply of 4556538401 - Telmisartan 80 mg tablets, with a period of performance through March 14, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $2,040.98 and covers the delivery of TELMISARTAN 20 MG TABLET 30S, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,509.24 firm-fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a medication used to treat hypertension. The award has an ultimate completion date of February 28, 2024 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery...
- SPE2DB20D7061Indefinite Delivery Contract
- SPE2DB20D7061-SPE2DB24FSNC5Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $7,183.74, is for the delivery of Telmisartan 20 mg tablets. The contract is a firm fixed-price Delivery Order with an ultimate completion date of April 26, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 31, 2025. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 4/25/24 |